Shah B, Challagulla S, Xu S, Williams R, et al. Zanubrutinib versus acalabrutinib indirect treatment comparison in relapsed or refractory mantle cell lymphoma. Leuk Lymphoma 2025 Sep 1:1-11. doi: 10.1080/10428194.2025.2541911.
PMID: 40889741